Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.41B |
| 2 |
American Tower
AMT
|
+$272M |
| 3 |
Microsoft
MSFT
|
+$271M |
| 4 |
Zoom
ZM
|
+$245M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$206M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$200M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$186M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$151M |
| 5 |
Pfizer
PFE
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.25% |
| 2 | Healthcare | 13.6% |
| 3 | Financials | 13.05% |
| 4 | Consumer Discretionary | 12.39% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABTX
2151
DELISTED
Allegiance Bancshares
ABTX
| $10.4M | ﹤0.01% |
305,843
+6,914
| +2% | +$210K |
|
2152
Modine Manufacturing
MOD
$10.6B
| $10.4M | ﹤0.01% |
829,625
+71,016
| +9% | +$689K |
|
2153
Ichor Holdings
ICHR
$2.35B
| $10.4M | ﹤0.01% |
345,009
+2,714
| +0.8% | +$76.8K |
|
|
UMH
2154
UMH Properties
UMH
$1.29B
| $10.4M | ﹤0.01% |
699,820
+146,968
| +27% | +$2.14M |
|
2155
BioXcel Therapeutics
BTAI
$26.8M
| $10.4M | ﹤0.01% |
14,015
+1,130
| +9% | +$880K |
|
|
DMC
2156
Del Monte Corp
DMC
$1.4B
| $10.3M | ﹤0.01% |
429,166
+719
| +0.2% | +$17.3K |
|
|
MAGN
2157
Magnera Corp
MAGN
$485M
| $10.3M | ﹤0.01% |
48,410
+416
| +0.9% | +$83.6K |
|
2158
Syndax Pharmaceuticals
SNDX
$1.77B
| $10.3M | ﹤0.01% |
463,176
+51,163
| +12% | +$1.06M |
|
|
FMTX
2159
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $10.3M | ﹤0.01% |
295,004
+35,165
| +14% | +$1.53M |
|
2160
Surgery Partners
SGRY
$2.02B
| $10.3M | ﹤0.01% |
354,835
+10,807
| +3% | +$269K |
|
|
ARR
2161
Armour Residential REIT
ARR
$2.35B
| $10.3M | ﹤0.01% |
190,720
+5,663
| +3% | +$291K |
|
2162
MannKind Corp
MNKD
$1.27B
| $10.3M | ﹤0.01% |
3,287,389
+236,172
| +8% | +$619K |
|
|
OSG
2163
Octave Specialty Group
OSG
$252M
| $10.3M | ﹤0.01% |
668,884
+2,648
| +0.4% | +$39K |
|
|
SP
2164
DELISTED
SP Plus Corporation
SP
| $10.3M | ﹤0.01% |
356,692
+4,078
| +1% | +$100K |
|
2165
Veritone
VERI
$109M
| $10.3M | ﹤0.01% |
361,021
+54,187
| +18% | +$938K |
|
2166
WisdomTree
WT
$3.37B
| $10.3M | ﹤0.01% |
1,916,514
-17,171
| -0.9% | -$73.9K |
|
2167
Protagonist Therapeutics
PTGX
$8.77B
| $10.2M | ﹤0.01% |
508,301
+69,187
| +16% | +$1.49M |
|
2168
Horizon Bancorp
HBNC
$1.06B
| $10.2M | ﹤0.01% |
646,044
+10,450
| +2% | +$143K |
|
2169
Gildan
GIL
$10.9B
| $10.2M | ﹤0.01% |
367,307
+29,948
| +9% | +$736K |
|
2170
Fulgent Genetics
FLGT
$528M
| $10.2M | ﹤0.01% |
196,312
+40,933
| +26% | +$1.71M |
|
|
TVRD
2171
Tvardi Therapeutics
TVRD
$18.1M
| $10.2M | ﹤0.01% |
18,775
+860
| +5% | +$451K |
|
2172
Ryanair
RYAAY
$31.8B
| $10.2M | ﹤0.01% |
231,283
+10,600
| +5% | +$416K |
|
2173
Weis Markets
WMK
$1.84B
| $10.2M | ﹤0.01% |
212,648
-1,311
| -0.6% | -$62.9K |
|
2174
IES Holdings
IESC
$15.5B
| $10.1M | ﹤0.01% |
220,443
+10,526
| +5% | +$412K |
|
|
TRST
2175
Trustco Bank Corp NY
TRST
$977M
| $10.1M | ﹤0.01% |
304,134
-5,831
| -2% | -$176K |
|
Similar funds
Geode Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Geode Capital Management held 4,369 positions worth $596B, up 17% from $510B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q4 2020 filing shows 215 new, 3,067 increased, 650 reduced and 100 closed positions. Its largest new stake was Apartment Income REIT Corp.: 2,223,585 shares worth $85.4M. The largest sale was Tiffany & Co., an estimated $206M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,223,585 shares worth $85.4M.
- Geode Capital Management added most to Tesla in Q4 2020, an estimated $2.41B increase.
- Geode Capital Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $131M.
- Geode Capital Management fully exited Tiffany & Co. in Q4 2020, selling an estimated $206M.
- Geode Capital Management's ten largest holdings make up 22% of its $596B portfolio in Q4 2020.
- Geode Capital Management opened 215 new positions and closed 100 in Q4 2020.
- Geode Capital Management's portfolio value rose 17% quarter-over-quarter to $596B.
Based on Geode Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.